1.Clinical analysis of arterial perfusion intervention combined with radiation and chemotherapy in the treatment of locally advanced cervical cancer
Chinese Journal of Postgraduates of Medicine 2014;37(15):46-48
Objective To analyze the effect of artery perfusion intervention combined with radiation and chemotherapy in the treatment of locally advanced cervical cancer,and to provide clinical reference.Methods One hundred and eighteen cases with locally advanced cervical cancer patients were divided into observation group and control group by random digits table method,each group 59 cases,all patients in two groups received preoperative chemoradiation,observation group based on this,and added arterial perfusion interventional chemotherapy,compared the clinical curative effect of two groups.Results The effective rate in observation group was significantly higher than that in control group[93.22%(55/59) vs.77.97%(46/59)] (x2 =5.567,P=0.018).Seventeen cases in observation group with Ⅰ and Ⅱ degree of nausea,vomiting,2 cases with Ⅲ degree of nausea,vomiting,4 cases with Ⅰ degree of bone marrow suppression,the incidence of adverse reactions were 38.98%(23/59);18 cases in control group with Ⅰ and Ⅱ degree of nausea,vomiting,3 cases with bone marrow suppression,the incidence of adverse reactions were 35.59% (21/59),there was no statistically significant difference between two groups (x2 =0.145,P =0.703).Conclusions Preoperative arterial perfusion intervention combined with chemoradiotherapy can effectively improve the curative effect for locally advanced cervical cancer,and has no increase in adverse reactions,and has important clinical value.
2.The curative effect research of the utilized timing of romethamine in cesarean section with central placenta previa
Chinese Journal of Postgraduates of Medicine 2014;37(12):13-15
Objective To explore the curative effect of the different utilized timing of romethamine in cesarean section with central placenta previa.Methods All of 148 patients with central placenta previa were divided into observation group (74 patients) and control group (74 patients) according to the serial number.The patients in observation group were given romethamine after breaking off umbilical core,the patients in control group were given romethamine after placental expulsion.The intraoperative blood loss,postoperative 24 h blood loss,operation time,rate of automatic placental expulsion and adverse reaction were compared.Results The intraoperative blood loss in observation group was less than that in control group[(503.5 ± 320.8) ml vs.(672.1 ± 409.6) ml],the rate of automatic placental expulsion was higher than that in control group [79.73% (59/74) vs.54.05% (40/74)],the operation time was less than that in control group [(42 ± 15) min vs.(55 ± 16) min],there was significant difference (P <0.05 or <0.01).The postoperative 24 h blood loss and the adverse reaction between two groups had no significant difference (P > 0.05).Conclusions In cesarean section with central placenta previa,given romethamine after breaking off umbilical core can improve the rate of automatic placental expulsion,shorten operation time,decrease intraoperative blood loss.It is worthy of spreading.
3.Progress of encephalopathy of premturity
International Journal of Pediatrics 2012;39(2):173-176
The encephalopathy of prematurity is a complex amalgam of primary destructive disease and secondary developmental disturbances.The interrelations between destructive and developmental mechanisms at cellular and molecular level in the genesis of the encephalopathy are emphasized and reviewed.We focus on its latest definition,microglia activation induced oligodendrocyte injury,neuronal/axonal impairments,and recent insights of thalamus,subplate neurons and cerebral cortex injury.
4.Clinical study of irbesartan and amlodipine on the primary effect of blood pressure variability in patients with hypertension
Chinese Journal of Primary Medicine and Pharmacy 2016;23(16):2476-2480,2481
Objective To study the effects of irbesartan and amlodipine on blood pressure variability (BPV) by observation of irbesartan and amlodipine in treatment of essential hypertension before and after the change of blood pressure.Methods 119 hypertensive patients were randomly divided into group A and group B according to age,sex, blood pressure,left ventricular mass index.60 patients were treated with irbesartan (group A),and another 59 patients were treated with amlodipine(group B).Liver and kidney function,blood glucose,cholesterol,low density lipoprotein,24h systolic blood pressure variation coefficient (24SCV),coefficient of variation of daytime systolic (dSCV),night systolic blood pressure variability index (nSCV),24h diastolic blood pressure coefficient of variation (24DCV),day-time diastolic blood pressure variability (dDCV),nocturnal diastolic blood pressure variation coefficient (nDCV),left ventricular mass index (LVMI),urine micro albumin,carotid intima -media thickness (IMT)level were examined at the 24th week of the therapy.Results (1 )The levels of 24h SCV,dSCV,nSCV after treatment were significantly lower than before treatment both in group A and group B (group A:24hSCV t =4.42;dSCV t =3.46;nSCV t =4.70, group B:24hSCV t =3.93;dSCV t =2.38;nSCV t =5.00,all P <0.01).Comparison of BPV between group A and group B after treatment,the 24hSCV,dSCV,nSCV of group A were lower than those of group B(24hSCV t =3.16;dSCV t =2.95,;nSCV t =2.26,all P <0.05).(2)The levels of 24hDCV,dDCV,nDCV after treatment were signifi-cantly lower than before treatment both in group A and group B(group A:24hDCV t =9.96;dDCV t =3.31;nDCV t =5.93,all P <0.01;group B:24hDCV t =5.38;dDCV t =2.19;nDCV t =5.76,all P <0.01).Comparison of BPV between group A and group B after treatment,24hDCV,dDCV,nDCV of group A were lower than those of group B (24hDCV t =2.42;dDCV t =1.44;nDCV t =2.45,all P <0.05).(3)The level of LVMI after treatment was signifi-cantly lower than before treatment both in group A and group B (group A:t =8.11,P <0.01;group B:t =7.28,all P <0.01).Comparison of LVMI between group A and group B after treatment,the LVMI of group A was lower than that of group B(t =3.75,P <0.01).(4)The level of urine micro albumin after treatment was significantly lower than before treatment both in group A and group B (group A:t =25.04;group B t =11.59,all P <0.01).Comparison of urine micro albumin between group A and group B after treatment,the level of group A was lower than that of group B (t =8.23,P <0.01).(5)The level of IMT after treatment was significantly lower than before treatment both in group A and group B (group A:t =5.58;group B t =4.10,all P <0.01).Comparison of IMT between group A and group B after treatment,the level of group A was lower than that of group B(t =1.98,P <0.05).Conclusion Irbesartan and amlodipine both can effectively reduce blood pressure and BPV.They both can protection of target organs in patients with hypertension.Irbesartan is better than amlodipine.
5.Enhancement of cisplatin -induced apoptosis in HL-60 cells by human telomerase reverse transcriptase antisense oligodeoxynucleotide
Chinese Journal of Pathophysiology 2001;17(5):396-399
AIM:To explore the effects of the combined use of human telomerase reverse transcriptase (hTERT) gene antisense oligodeoxynucleotide (ASODN) and cisplatin on apoptosis of HL-60 cells. METHODS:PCR-ELISA was used to determine telomerase activity in HL-60 cells untreated or treated with ASODN, the expression levels of hTERT protein were assayed by immunofluorescence using fluoresce isothiocyanate (FITC) label. Apoptosis was detected by DNA electrophoresis and flow cytomertric cell cycle analysis. RESULTS:The expression levels of hTERT protein and telomerase activity in HL-60 cells treated with ASODN were shown to decrease with time, the DNA fragments were obviously found and the percentage of apoptosis cells was significantly enhanced in HL-60 cells with the combined use of hTERT ASODN and cisplatin compared with the combined use of hTERT sense oligodeoxynucleotide and cisplatin or cisplatin alone, respectively. CONCLUSION:Inhibition of telomerase activity by hTERT ASODN increases the cisplatin-induced apoptosis of HL-60 cells.
6.Preparing domain Ⅱ F2 fragment of Plasmodium falciparum 175000 erythrocyte binding antigen and its combined immunization
Academic Journal of Second Military Medical University 1982;0(01):-
Objective:To synthesize the eba 175Ⅱf2 gene of Plasmodium falciparum and express it in Pichia pastoris in the secreting form. The recombinant protein and PfCP 2.9 protein were used for combined immunization to see if there is antigen competition. Methods: Asymmetric PCR based metho d was utilized to synthesize the 959bp eba 175Ⅱf2 gene. Plasmid containing the synthetic gene was introduced into Pichi a pa storis by electroporation for inducible expression. The recombinant EBA 175Ⅱ F2 p rotein was purified by ion exchange and gel filtration ch romatography. Results: The eba 175Ⅱf2 gene was successfully ex p ressed in Pichia pastoris in the secreting form. The antibody titers in mice immunized with the combined EBA 175ⅡF2 and PfCP 2.9 proteins w ere much higher tha n those with individual protein by ELISA. Conclusion: No antigen competition is found when using the combined EBA 175ⅡF2 and PfCP 2.9 immunization in mice, indicating the potential of combining the 2 antigens for vaccination.
7.bcl-2 antisense oligodeoxynucleotide increases sensitivity of NCI-H460 cell lines to docetaxel and radiation
Academic Journal of Second Military Medical University 1985;0(05):-
Objective:To determine whether the bcl-2 antisense oligonucleotide (ASODN) can increase the sensitivity of NCI-H460 cell lines to docetaxel or radiation. Methods: Docetaxel in combination with bcl-2 ASODN or non-sense oligonucleotide (NSODN) was used to treat NCI-H460 cells, and then IC_~50 of docetaxel against NCI-H460 cells was determined with MTT method. In radiation group, NCI-H460 cells were divided into pure radiation, radiation plus bcl-2 ASODN, and radiation plus NSODN groups. The inhibition rates of cell growth were assayed by MTT, and the expression levels of Bcl-2 protein were assayed by immunofluorescence. Results: IC_~50 in bcl-2 ASODN plus docetaxel, pure docetaxel and NSODN plus docetaxel groups was (0.101?0.009) ?mol/L,(0.183?0.018)?mol/L, and (0.179?0.016)?mol/L, respectively. The differences between the first group and the latter 2 groups were significant (P
8.Right-sided chest lead electrocardiographic abnormalities in acute pulmonary embolism
Chinese Journal of General Practitioners 2002;0(02):-
Objective To identify right-sided chest lead electrocardiograph (ECG) abnormalities in acute pulmonary embolismMethods Changes of routinely recorded 12-lead and right-sided chest leads V 3R, V 4R and V 5R ECGs in 98 patients with suspected pulmonary embolism hospitalized at Ninghe County Hospital during March 1999 to October 2003 were analyzed retrospectively Parameters of both right and left-sided ECGs available were measured and comparedResults Diagnosis of acute pulmonary embolism was established in only 23 (234%) of 98 suspected patients, 18 men (78%) and 5 women (22%), with mean age of (48 ? 10) ECG changes suggestive of acute right ventricular strain were found in both right and left-sided leads in 18 (78%) of 23 patients with pulmonary embolism, and their ECG changes disappeared within 24 hours after admission or onset of symptoms with pulmonary embolism in 13 (72%) of them ST segment elevation in leads V 3R, V 4R, V 5R ,and abnormalities in standard 12-lead ECGs were found in nine (39%), and five (22%) of them with a diagnosis of pulmonary embolism had normal left-sided ECGs, but elevated ST segment and qr or QS pattern (prominent q waves) in leads V 3R, V 4R and V 5R in their right-sided ECGs Thirteen (565%) of them showed ST-segment elevated in leads V 3R, V 4R and V 5R,and 20 (87%) showed qr configuration in lead V 3RConclusions Patients with acute pulmonary embolism often show characteristic ECG changes in right-sided chest leads When pulmonary embolism is suspected, especially no typical changes in routinely-recorded standard 12-lead ECGs can be found, right-sided chest lead ECG should be performed
9.Enhancement of cisplatin -induced apoptosis in HL-60 cells by human telomerase reverse transcriptase antisense oligodeoxynucleotide
Chinese Journal of Pathophysiology 1989;0(05):-
AIM: To explore the effects of the combined use of human telomerase reverse transcriptase (hTERT) gene antisense oligodeoxynucleotide (ASODN) and cisplatin on apoptosis of HL-60 cells. METHODS: PCR-ELISA was used to determine telomerase activity in HL-60 cells untreated or treated with ASODN, the expression levels of hTERT protein were assayed by immunofluorescence using fluoresce isothiocyanate (FITC) label. Apoptosis was detected by DNA electrophoresis and flow cytomertric cell cycle analysis. RESULTS: The expression levels of hTERT protein and telomerase activity in HL-60 cells treated with ASODN were shown to decrease with time, the DNA fragments were obviously found and the percentage of apoptosis cells was significantly enhanced in HL-60 cells with the combined use of hTERT ASODN and cisplatin compared with the combined use of hTERT sense oligodeoxynucleotide and cisplatin or cisplatin alone, respectively. CONCLUSION: Inhibition of telomerase activity by hTERT ASODN increases the cisplatin-induced apoptosis of HL-60 cells.
10.Maternal serum level of adiponectin and expression of adiponectin mRNA in subcutaneous and omental adipose tissues in women with preeclampsia
Chinese Journal of Obstetrics and Gynecology 2009;44(8):578-582
creased maternal serum adiponectin level may be involved in the pathogenesis of pre-eclampsia and also may contribute to the reduced expression of adiponectin in the omental adipose tissue.